Millions of people with severe burns or diabetic skin ulcers could benefit from an experimental enhancement to a next-generation covering that is already healing difficult wounds.
spinoffs
Nanoparticles improve tumor treatment in mice
In mouse models of human lung cancer, the improved drug inhibited tumor growth more effectively than the standard drug. “Ultimately, our goal is to get this into human beings,” says pharmacy professor Glen Kwon.
New measure of insulin-making cells could gauge diabetes progression, treatment
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.
Plant derivative could help patients reliant on tube feeding
Experiments suggest it could help people who must obtain “enteral nutrition” — often due to swallowing problems related to cancer, neurological disease, surgery or developmental delay.
Madison startup advances three-in-one cancer drug rooted at UW
The first target for Co-D is angiosarcoma, a rare and lethal cancer that arises from blood vessels.
UW-Madison spinoff gets FDA OK for bacteria-killing wound dressing
Microlyte, patented by Imbed Biosciences, will compete in the $2 billion market sector of “advanced wound dressings,” which are used to treat ulcers, burns, bedsores and other difficult wounds.